166 related articles for article (PubMed ID: 24488056)
1. Maternal serum analyte screening for fetal aneuploidy.
Chasen ST
Clin Obstet Gynecol; 2014 Mar; 57(1):182-8. PubMed ID: 24488056
[TBL] [Abstract][Full Text] [Related]
2. First trimester screening for other trisomies than trisomy 21, 18, and 13.
Tørring N; Petersen OB; Becher N; Vogel I; Uldbjerg N; ;
Prenat Diagn; 2015 Jun; 35(6):612-9. PubMed ID: 25708180
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
4. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
6. Screening for fetal aneuploidy.
Rink BD; Norton ME
Semin Perinatol; 2016 Feb; 40(1):35-43. PubMed ID: 26725144
[TBL] [Abstract][Full Text] [Related]
7. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
8. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
Senat MV; Rozenberg P; Bernard JP; Ville Y
J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
[No Abstract] [Full Text] [Related]
9. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
10. hCG in screening for aneuploidy: a possible role for its glycoforms?
Brun S; Leguy MC; Bruneel A; Fournier T; Anselem O; Guibourdenche J
Placenta; 2014 Jun; 35(6):425-7. PubMed ID: 24731729
[TBL] [Abstract][Full Text] [Related]
11. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
[TBL] [Abstract][Full Text] [Related]
12. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
13. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
[TBL] [Abstract][Full Text] [Related]
14. Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center.
Alamillo CM; Krantz D; Evans M; Fiddler M; Pergament E
Prenat Diagn; 2013 Mar; 33(3):251-6. PubMed ID: 23354915
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
Wenstrom KD; Owen J; Chu Dc; Boots L
Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
[TBL] [Abstract][Full Text] [Related]
17. [What are the real purpose and scope of screening for aneuploidy?].
Quibel T; Rozenberg P
Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
[TBL] [Abstract][Full Text] [Related]
18. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
[TBL] [Abstract][Full Text] [Related]
19. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN
Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
